2018-07-01
Response to: ‘Different glucosamine sulfate products generate different outcomes on osteoarthritis symptoms’ by reginster et al
Publication
Publication
Annals of the Rheumatic Diseases: an international peer-reviewed journal for health professionals and researchers in the rheumatic diseases , Volume 77 - Issue 7
| Additional Metadata | |
|---|---|
| doi.org/10.1136/annrheumdis-2017-212276, hdl.handle.net/1765/111646 | |
| The OA Trial Bank | |
| Annals of the Rheumatic Diseases: an international peer-reviewed journal for health professionals and researchers in the rheumatic diseases | |
| Organisation | Department of General Practice |
|
Runhaar, J., Rozendaal, R., van Middelkoop, M., Bijlsma, H., Doherty, M., Dziedzic, K., … Bierma-Zeinstra, S. (2018). Response to: ‘Different glucosamine sulfate products generate different outcomes on osteoarthritis symptoms’ by reginster et al. Annals of the Rheumatic Diseases: an international peer-reviewed journal for health professionals and researchers in the rheumatic diseases, 77(7). doi:10.1136/annrheumdis-2017-212276 |
|